Adicet Bio Stock Forecast
NASDAQ: ACETHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Pre-market: 5.80 +1.05%
ACET analyst consensus
Consensus (6 analysts)
strong_buy
Avg. price target
$34.83+506.79%
- Strong buy 0
- Buy 6
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 6 Wall Street analysts covering Adicet Bio (2026-10-09), 6 rate the stock a buy or strong buy, 0 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "strong_buy". The average 12-month price target is $34.83, with a high estimate of $90.00 and a low estimate of $18.00. The average target implies upside of 506.8% from the current price of $5.74.
The spread between the highest and lowest targets is 400.0%, a wide range that reflects significant disagreement among analysts. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for ACET.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 0 | 0% |
| Buy | 6 | 100% |
| Hold | 0 | 0% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-09.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $18.00 | +213.59% |
| Average target | $34.83 | +506.79% |
| High target | $90.00 | +1467.94% |